Literature DB >> 14153286

EXPERIMENTS ON DETERMINATION OF MELPHALAN BY FLUORESCENCE. INTERACTION WITH PROTEIN AND VARIOUS SOLUTIONS.

M A CHIRIGOS, J A MEAD.   

Abstract

Entities:  

Keywords:  BLOOD PROTEINS; CHEMISTRY, ANALYTICAL; CHROMATOGRAPHY; EXPERIMENTAL LAB STUDY; FLUORESCENCE; FLUOROMETRY; HYDROGEN-ION CONCENTRATION; MELPHALAN; SOLUTIONS; ULTRAVIOLET RAYS

Mesh：

Substances：

Year:  1964        PMID： 14153286     DOI： 10.1016/0003-2697(64)90130-7

Source DB:  PubMed          Journal:  Anal Biochem        ISSN： 0003-2697            Impact factor:   3.365


× No keyword cloud information.
  6 in total

1.  Relevance of the hydrolysis and protein binding of melphalan to the treatment of multiple myeloma.

Authors:  S Gera; E Musch; H K Osterheld; U Loos
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  A sensitive high-performance liquid chromatographic assay for melphalan and its hydrolysis products in blood and plasma.

Authors:  H K Osterheld; E Musch; G E von Unruh; U Loos; H Rauschecker; B J Mühlenbruch
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

3.  Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat.

Authors:  N H Greig; D J Sweeney; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

4.  Distribution of nitroimidazoles and L-phenylalanine mustard in mammary adenocarcinoma 16/C tumors.

Authors:  P E Noker; L Simpson-Herren; S D Wagoner
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  Melphalan concentration dependent plasma protein binding in healthy humans and rats.

Authors:  N H Greig; D J Sweeney; S I Rapoport
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 6.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.